Mary, our IRB does not consider the source of funding, if any.  We've never thought it was relevant to the protection of human subjects.  I guess I can imagine a case where it might be, e.g. if a giganto drug company was showering a med school (including PI's and/or subjects) with money to perform a clinical trial, the IRB might want to know that so that they could give extra scrutiny.  Fortunately, we don't do anything like that here.

Regards, Bill

Bill Campbell
Director, Grants & Research
University of Wisconsin-River Falls

======================================================================
 Instructions on how to use the RESADM-L Mailing List, including
 subscription information and a web-searchable archive, are available
 via our web site at http://www.hrinet.org (click on "Listserv Lists")
======================================================================